Premium
Imaging misfolded tau in the retina
Author(s) -
Kayabasi Umur A
Publication year - 2020
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1002/alz.047015
Subject(s) - retinal , retina , pathology , fundus (uterus) , lesion , medicine , anatomy , ophthalmology , biology , neuroscience
Background Recent research suggests that Tau is the culprit lesion along with neuroinflammation in the etiology of Alzheimer' s Disease (AD). Retina is the extention of the brain and is the most easily approachable part of the central nervous system. Detection of thepathological protein accumulations may be possible by using spectral domain optical coherescent tomography (SD‐OCT) and fundus autofluorescein (FAF). There is evidence showing that retinal plaques start accumulating even earlier than the ones in the brain. Most recent Tau protein images in thebrain consist of normal or reverse C‐shaped paired hellical filaments. Method 20 patients with PET proven AD were examined by SD‐OCT and FAF. Mean agewas 72. Hypo or hyperfluorescent retinal lesions were scanned by SDOCT and Neurofibrillary Tangles (NFT) in a masked fashion. The researchers agreed on the shape of the lesions. Both C‐shaped (normal or reverse) NFTsand thinner fibrillary structures were taken into consideration. Result In all the patients, NFTs that exactly corresponded with the histopathologic and cryo‐EM images of Tau (Figure 1) in terms of shape and dimension were detected along with thin fibrils and lesions similar to amyloid beta. The number of the retinal filaments and other abnormal proteins was in concordance with the severity of the disease process. The advanced retinal lesions had normal or reverse paired C shapes (Figure 2) and thin fibrils had the shape of histopathologic images seen in early developmental stages of the disease. Conclusion Retinal images of Tau were disclosed for the first time in live AD patients. Retinal neuroimaging is a trustable biomarker and tool for monitoring the disease.